Georgia Healthcare Group PLC GHG signs a partnership agreement with the ALIMP (8780T)

TIDMGHG

RNS Number : 8780T

Georgia Healthcare Group PLC

25 March 2019

London, 25 March 2019

GHG signs a partnership agreement with the Association of Leading

Israeli Medical Professors

Georgia Healthcare Group PLC ("GHG" or the "Group") announces that its Hospitals business has signed a partnership agreement with the Association of Leading Israeli Medical Professors ("ALIMP"), under which the association member professors will provide their service at GHG's healthcare facilities, for Georgian as well as for international patients. GHG healthcare facilities will be the only hospitals from post-soviet countries with whom the ALIMP can partner for the next eight years.

Members of the association, a group of internationally recognised Israeli doctors, are specialists in different medical fields including cardiac surgery, orthopaedic surgery, thoracic surgery, bariatric surgery, urology and gynaecology. The partnership is a unique opportunity for both local and international patients to receive the highest quality of treatment at an affordable price. The members of ALIMP will also be engaged in training and upskilling our medical professionals and resident doctors, giving them the possibility to incorporate the latest scientific approaches in medicine at GHG hospitals.

"I am very pleased that GHG's Hospitals business has started another successful project, that will significantly contribute towards its newly declared strategy to develop medical tourism in the country. After the renovation works carried out at our hospitals over the past few years, and particularly after opening our flagship Regional Hospital, we are now ready to serve our patients with the best possible healthcare infrastructure. This, combined with the best-in-class human capital recognised internationally, will further enable us to provide Georgian citizens with access to high-quality treatment without leaving the country and to attract more international patients, ensuring further expansion and growth. The knowledge and experience sharing is a part of the partnership that we believe our medical staff will strongly benefit from and contribute to their further development." - commented Nikoloz Gamkrelidze, CEO of Georgia Healthcare Group.

Name of authorised official of issuer responsible for making notification:

Ketevan Kalandarishvili, Head of Investor Relations

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 37 hospitals and 16 district polyclinics. GHG is the single largest market participant, accounting for 25% of total hospital bed capacity in the country, as of 31 December 2018. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 27% market share based on net insurance premiums earned and approximately c.230,000 insurance customers as of now. GHG employed a total of c.15,900 people as at 31 December 2018, including c.3,600 physicians and 3,300 pharmacists.

For further information, please visit ghg.com.ge or contact:

 
      Nikoloz Gamkrelidze            Irakli Gogia                      Ketevan Kalandarishvili 
      CEO                            CFO                               Head of Investor 
                                                                        Relations 
                                                                          [phone] 
      [phone] (5077)             [phone] (5088)            (5079) 
      [e-mail]            [e-mail]            [e-mail] 
 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCBGGDXBGDBGCU

(END) Dow Jones Newswires

March 25, 2019 06:03 ET (10:03 GMT)